BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou MS, Nasir M, Farhat LC, Kook M, Artukoglu BB, Bloch MH. Meta-analysis: Pharmacologic Treatment of Restricted and Repetitive Behaviors in Autism Spectrum Disorders. J Am Acad Child Adolesc Psychiatry 2021;60:35-45. [PMID: 32387445 DOI: 10.1016/j.jaac.2020.03.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Alymov AA, Kapitsa IG, Voronina TA. Neurochemical Mechanisms of Pathogenesis and Pharmacological Correction of Autism Spectrum Disorders: Current Concepts and Prospects. Neurochem J 2021;15:129-38. [DOI: 10.1134/s1819712421020033] [Reference Citation Analysis]
2 Hendren RL. Editorial: What to Do About Rigid, Repetitive Behaviors in Autism Spectrum Disorder? J Am Acad Child Adolesc Psychiatry 2021;60:22-3. [PMID: 33238188 DOI: 10.1016/j.jaac.2020.11.009] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, Ostinelli EG, Zangani C, Fornaro M, Estradé A, Fusar-Poli P, Carvalho AF, Solmi M. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry 2021;20:244-75. [PMID: 34002501 DOI: 10.1002/wps.20881] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
4 Murillo-de-Ozores AR, Chávez-Canales M, de Los Heros P, Gamba G, Castañeda-Bueno M. Physiological Processes Modulated by the Chloride-Sensitive WNK-SPAK/OSR1 Kinase Signaling Pathway and the Cation-Coupled Chloride Cotransporters. Front Physiol 2020;11:585907. [PMID: 33192599 DOI: 10.3389/fphys.2020.585907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Lord C, Charman T, Havdahl A, Carbone P, Anagnostou E, Boyd B, Carr T, de Vries PJ, Dissanayake C, Divan G, Freitag CM, Gotelli MM, Kasari C, Knapp M, Mundy P, Plank A, Scahill L, Servili C, Shattuck P, Simonoff E, Singer AT, Slonims V, Wang PP, Ysrraelit MC, Jellett R, Pickles A, Cusack J, Howlin P, Szatmari P, Holbrook A, Toolan C, McCauley JB. The Lancet Commission on the future of care and clinical research in autism. Lancet 2021:S0140-6736(21)01541-5. [PMID: 34883054 DOI: 10.1016/S0140-6736(21)01541-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Uljarević M, Frazier TW, Jo B, Billingham WD, Cooper MN, Youngstrom EA, Scahill L, Hardan AY. Big Data Approach to Characterize Restricted and Repetitive Behaviors in Autism. J Am Acad Child Adolesc Psychiatry 2021:S0890-8567(21)01317-4. [PMID: 34391858 DOI: 10.1016/j.jaac.2021.08.006] [Reference Citation Analysis]
7 Gandhi T, Lee CC. Neural Mechanisms Underlying Repetitive Behaviors in Rodent Models of Autism Spectrum Disorders. Front Cell Neurosci 2020;14:592710. [PMID: 33519379 DOI: 10.3389/fncel.2020.592710] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jacques C, Courchesne V, Mineau S, Dawson M, Mottron L. Positive, negative, neutral-or unknown? The perceived valence of emotions expressed by young autistic children in a novel context suited to autism. Autism 2022;:13623613211068221. [PMID: 35168392 DOI: 10.1177/13623613211068221] [Reference Citation Analysis]
9 Löscher W, Kaila K. CNS pharmacology of NKCC1 inhibitors. Neuropharmacology 2021;:108910. [PMID: 34883135 DOI: 10.1016/j.neuropharm.2021.108910] [Reference Citation Analysis]
10 Tian J, Gao X, Yang L. Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics. Front Neurosci 2022;16:780407. [DOI: 10.3389/fnins.2022.780407] [Reference Citation Analysis]
11 Siafis S, Çıray O, Wu H, Schneider-Thoma J, Bighelli I, Krause M, Rodolico A, Ceraso A, Deste G, Huhn M, Fraguas D, San José Cáceres A, Mavridis D, Charman T, Murphy DG, Parellada M, Arango C, Leucht S. Pharmacological and dietary-supplement treatments for autism spectrum disorder: a systematic review and network meta-analysis. Mol Autism 2022;13:10. [PMID: 35246237 DOI: 10.1186/s13229-022-00488-4] [Reference Citation Analysis]
12 Wang T, Shan L, Miao C, Xu Z, Jia F. Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis. Front Psychiatry 2021;12:751575. [PMID: 34867539 DOI: 10.3389/fpsyt.2021.751575] [Reference Citation Analysis]
13 Shehi E, Shah H, Singh A, Pampana VS, Kaur G. The Linkage Between Autism Spectrum Disorder and Dup15q Syndrome: A Case Report. Cureus. [DOI: 10.7759/cureus.24205] [Reference Citation Analysis]
14 Arranz MJ, Salazar J, Bote V, Artigas-baleri A, Serra-llovich A, Triviño E, Roige J, Lombardia C, Cancino M, Hernandez M, Cendros M, Duran-tauleria E, Maraver N, Hervas A. Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers. Pharmaceutics 2022;14:999. [DOI: 10.3390/pharmaceutics14050999] [Reference Citation Analysis]